A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...

Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...

AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.

Healey & AMG Center for ALS at Massachusetts General Hospital Merit Cudkowicz, M.D., M.Sc. said. "The need for new treatments for people living with ALS has never been greater. PrimeC has great ...

Clene (CLNN) and its subsidiary, Clene Nanomedicine announced new evidence from a cross-regimen, post hoc analysis of long-term survival in ...

ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at ...

The 2025 Walk to Defeat ALS Sarasota will be held on April 12 at 10 a.m. at Payne Park and registration to participate and support the event is underway. Amyotrophic lateral sclerosis (ALS ...